PMID- 8407954 OWN - NLM STAT- MEDLINE DCOM- 19931124 LR - 20210210 IS - 0021-9258 (Print) IS - 0021-9258 (Linking) VI - 268 IP - 28 DP - 1993 Oct 5 TI - Ca(2+)-dependent and thapsigargin-inhibited phosphorylation of Na+,K(+)-ATPase catalytic domain following chimeric recombination with Ca(2+)-ATPase. PG - 21185-92 AB - Two chimeric proteins comprising the Na,K-ATPase catalytic domain (large cytosolic loop) and the two flanking regions of the Ca-ATPase were obtained by transient or stable expression in mammalian cells transfected with recombinant DNA. In the first chimera (CpNC), a large portion (containing the nucleotide-binding site) of the cytosolic loop between putative membrane spans M4 and M5 of the sarcoendoplasmic reticulum Ca2+ (SERCA) 1 (fast muscle) ATPase was replaced by the corresponding portion of the Na,K-ATPase alpha 1 subunit. In the second chimera (CNpC), an even larger portion (containing the nucleotide-binding site and the phosphorylation site) of the analogous cytosolic loop of the SERCA2 (cardiac muscle) ATPase was replaced by the corresponding portion of the Na,K-ATPase alpha 1 subunit. Steady state Ca2+ transport and coupled ATP hydrolysis by the chimeric proteins were negligible as compared to those obtained with SERCA enzymes. Nevertheless, the chimeric proteins were able to utilize ATP to form phosphoenzyme levels equal to those formed by SERCA ATPases. Chimeric and SERCA enzymes exhibited an identical Ca2+ requirement for ATP utilization and sensitivity to thapsigargin (TG) which is a specific inhibitor of SERCA ATPase and not of Na,K-ATPase. Furthermore, both SERCA and chimeric enzymes could be phosphorylated with P(i), and this reaction required removal of Ca2+. In comparative experiments, the functional pattern of seemingly unaffected phosphoenzyme formation and inhibited Ca2+ transport was produced in the SERCA ATPase even by single mutation of Pro337 to Ala, evidently due to defective protein conformation. Retention of Ca2+ and TG sensitivity by the chimeric proteins demonstrates that the Ca(2+)- and TG-binding domains do not reside within the cytosolic loop replaced by chimeric substitution and strongly support previous studies suggesting that binding of calcium required for enzyme activation occurs within the membrane-bound region of the SERCA ATPases (Clarke et al., 1989a; Sumbilla et al., 1991). FAU - Sumbilla, C AU - Sumbilla C AD - Department of Biological Chemistry, University of Maryland, Baltimore 21201. FAU - Lu, L AU - Lu L FAU - Lewis, D E AU - Lewis DE FAU - Inesi, G AU - Inesi G FAU - Ishii, T AU - Ishii T FAU - Takeyasu, K AU - Takeyasu K FAU - Feng, Y AU - Feng Y FAU - Fambrough, D M AU - Fambrough DM LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - J Biol Chem JT - The Journal of biological chemistry JID - 2985121R RN - 0 (DNA, Single-Stranded) RN - 0 (Recombinant Fusion Proteins) RN - 0 (Terpenes) RN - 67526-95-8 (Thapsigargin) RN - 9DLQ4CIU6V (Proline) RN - EC 7.2.2.10 (Calcium-Transporting ATPases) RN - EC 7.2.2.13 (Sodium-Potassium-Exchanging ATPase) RN - SY7Q814VUP (Calcium) SB - IM MH - Amino Acid Sequence MH - Animals MH - Base Sequence MH - Biological Transport MH - Calcium/*metabolism MH - Calcium-Transporting ATPases/antagonists & inhibitors/*genetics MH - Cells, Cultured MH - Chickens MH - DNA, Single-Stranded MH - Hydrolysis MH - Mice MH - Microsomes/metabolism MH - Molecular Sequence Data MH - Mutation MH - Phosphorylation MH - Proline/genetics MH - Recombinant Fusion Proteins/genetics/metabolism MH - Recombination, Genetic MH - Sarcoplasmic Reticulum/enzymology MH - Sequence Homology, Amino Acid MH - Sodium-Potassium-Exchanging ATPase/antagonists & inhibitors/genetics/*metabolism MH - Terpenes/*pharmacology MH - Thapsigargin MH - Transfection EDAT- 1993/10/05 00:00 MHDA- 1993/10/05 00:01 CRDT- 1993/10/05 00:00 PHST- 1993/10/05 00:00 [pubmed] PHST- 1993/10/05 00:01 [medline] PHST- 1993/10/05 00:00 [entrez] AID - S0021-9258(19)36908-X [pii] PST - ppublish SO - J Biol Chem. 1993 Oct 5;268(28):21185-92.